The advent of new surgical techniques is to be welcomed. Our hopes of improving the care of our patients is the driving force behind the many innovations that have occurred in surgery over the last 50 years. However, we now work in a profession that strives to provide evidence-based care, and the surgical community has an obligation to see these techniques introduced in a controlled and appropriate manner.
When laparosopic surgery was introduced in the late 1980s, the introduction was uncontrolled and the price for this was an increase in the rate of avoidable complications. The lessons of the introduction of the early laparoscopic procedures, particularly laparoscopic cholecystectomy, must be used to provide a safe environment for the introduction of other forms of novel laparoscopic surgery.
In surgical oncology there are two aspects to the practice that require evaluation before these techniques should be advocated for widespread use. Uyama's paper in this issue of the journal [1] describes a technical solution to the delivery of part of a laparoscopic resection for cancer and demonstrates that the procedure is feasible. This paper, with a number of others, has demonstrated that the procedure is deliverable, but the publications to date are largely case studies or retrospective analyses [2] [3] [4] [5] . However, not all deliverable procedures result in an improvement in the overall care of the patient. It is vital with the evolution of laparoscopic or laparoscopically assisted surgery for gastric cancer that it is subject to the same rigorous standards of evaluation as the introduction of other forms of novel therapies.
There was immense interest and enthusiasm for the introduction of laparoscopic colorectal surgery, and this has now been tempered by experience. The value of the technique is now subject to a number of randomized trials, and evaluation of the data by the National Insti- 
